Aurinia Reports Third Quarter 2019 Financial Results and Recent Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Aurinia Reports Third Quarter 2019 Financial Results and Recent Operational Highlights

Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 6c

November 14, 2019 4:14 PM EST

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q3 EPS of ($0.21), $0.06 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $230 thousand versus the consensus estimate of $50 thousand.

As we look forward to results from the AURORA Phase 3 trial for LN... More